BCL-2 inhibitor APG-2575 promotes anti-tumor immunity through converting tumor-associated macrophages into M1 phenotype in non-small cell lung cancer

被引：0
|
作者：
Luo, Fan [1 ]
Lu, Fei-teng [1 ]
Qiu, Miao-zhen [1 ]
Pan, Wen-tao [1 ]
Zhang, Lin [1 ]
Zhao, Hong-yun [1 ]
Zhang, Li [1 ]
Yang, Da-jun [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5191
引用
收藏
页数：1
相关论文
共 50 条
  • [1] BCL-2 inhibitor APG-2575 promotes anti-tumor efficacy of immune checkpoint blockade through converting tumor-associated macrophages into M1 phenotype in non-small cell lung cancer.
    Luo, Fan
    Lu, Fei Teng
    Qiu, Miao Zhen
    Pan, Wen Tao
    Zhang, Lin
    Zhao, Hong Yun
    Zhang, Li
    Yang, Da Jun
    CANCER RESEARCH, 2021, 81 (13)
  • [2] The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
    Luo, Fan
    Li, Han
    Ma, Wenjuan
    Cao, Jiaxin
    Chen, Qun
    Lu, Feiteng
    Qiu, Miaozhen
    Zhou, Penghui
    Xia, Zengfei
    Zeng, Kangmei
    Zhan, Jianhua
    Zhou, Ting
    Luo, Qiuyun
    Pan, Wentao
    Zhang, Lin
    Lin, Chaozhuo
    Huang, Yan
    Zhang, Li
    Yang, Dajun
    Zhao, Hongyun
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (01) : 60 - 79
  • [3] The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
    Fan Luo
    Han Li
    Wenjuan Ma
    Jiaxin Cao
    Qun Chen
    Feiteng Lu
    Miaozhen Qiu
    Penghui Zhou
    Zengfei Xia
    Kangmei Zeng
    Jianhua Zhan
    Ting Zhou
    Qiuyun Luo
    Wentao Pan
    Lin Zhang
    Chaozhuo Lin
    Yan Huang
    Li Zhang
    Dajun Yang
    Hongyun Zhao
    Cellular & Molecular Immunology, 2024, 21 : 60 - 79
  • [4] The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
    Junliang Ma
    Lunxu Liu
    Guowei Che
    Nanbin Yu
    Fuqiang Dai
    Zongbing You
    BMC Cancer, 10
  • [5] The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time
    Ma, Junliang
    Liu, Lunxu
    Che, Guowei
    Yu, Nanbin
    Dai, Fuqiang
    You, Zongbing
    BMC CANCER, 2010, 10
  • [6] M2 tumor-associated macrophages induce tumor progression in non-small cell lung cancer
    Sumitomo, Ryota
    Hirai, Tatsuya
    Huang, Cheng-long
    CANCER SCIENCE, 2021, 112 : 500 - 500
  • [7] The prognostic influence of tumor infiltrating M1 and M2 phenotype macrophages in resected non-small cell lung cancer
    Jackute, Jurgita
    Zemaitis, Marius
    Pranys, Darius
    Sitkauskiene, Brigita
    Miliauskas, Skaidrius
    Sakalauskas, Raimundas
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [8] Tumor-Associated Macrophages: Key Players in the Non-Small Cell Lung Cancer Tumor Microenvironment
    Lv, Tongtong
    Fan, Rui
    Wu, Jiaqi
    Gong, Haolan
    Gao, Xiaoru
    Liu, Xin
    Gong, Yixin
    Luo, Bo
    Zhang, Yanhua
    Peng, Xiaochun
    Liang, Gai
    CANCER MEDICINE, 2025, 14 (03):
  • [9] 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages
    Wu, Zhihui
    Zhou, Juan
    Chen, Fangwei
    Yu, Jing
    Li, Hui
    Li, Qingfeng
    Li, Wencan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 104
  • [10] The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer
    Feng, Yun
    Wan, Huanying
    Liu, Jialin
    Zhang, Ruifeng
    Ma, Qinyun
    Han, Bing
    Xiang, Yi
    Che, Jiaming
    Cao, Huangming
    Fei, Xiaochun
    Qiu, Weicheng
    ONCOLOGY REPORTS, 2010, 23 (04) : 941 - 948
12345